paramyxoviruses

New Antiviral Drug Developed for Orthoparamyxoviruses

Researchers at Georgia State University have developed a new oral antiviral drug, GHB-85310, effective against orthoparamyxoviruses like measles and respiratory syncytial virus. The drug, taken once daily, shows high efficacy in animal models and human airway organ cultures, offering hope for treating these significant human health threats, especially for vulnerable populations.